Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
New Zealand's Medsafe is independently testing Estradot patches after 149 women reported poor adhesion and ineffective relief.
Medsafe has launched independent testing of Estradot oestrogen patches after 149 complaints from New Zealand women reporting poor adhesion and ineffective symptom relief.
The manufacturer, Sandoz, acknowledged about 50 complaints and tested U.S. batches, but Medsafe is now assessing New Zealand-specific batches using local labs due to concerns over testing adequacy.
The agency is investigating whether the issue is unique to New Zealand or part of a broader international pattern, with similar reports in the UK.
Medsafe is working with Sandoz and global regulators, emphasizing transparency and regular updates.
The Ministry of Health maintains the product remains effective for most users.
Medsafe de Nueva Zelanda está probando los parches de Estradot de forma independiente después de que 149 mujeres informaran de una mala adhesión y un alivio ineficaz.